Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 44 Urinary Bladder Neoplasms 42 Testicular Neoplasms 30 Carcinoma, Transitional Cell 30 Ovarian Neoplasms 28 Testicular Germ Cell Tumor 16 Carcinoma, Non-Small-Cell Lung 14 Melanoma 11 Kidney Neoplasms 11 Carcinoma, Renal Cell 11 Breast Neoplasms 11 Wilms Tumor 10 Urethral Neoplasms 10 Teratoma 10 Sarcoma 10 Pancreatic Neoplasms 10 Central Nervous System Neoplasms 10 Colorectal Neoplasms 9 Neuroectodermal Tumors, Primitive, Peripheral 8 Neoplasm Metastasis 8 Stomach Neoplasms 7 Ovarian Germ Cell Cancer 7 Neoplasms 7 Seminoma 6 Osteosarcoma 6 Neuroblastoma 6 Lung Neoplasms 6 Head and Neck Neoplasms 6 Ureteral Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5

Interventions

enzalutamide 7 Prednisone 7 cabazitaxel 6 Radiosurgery 6 Docetaxel 5 Androgen Antagonists 4 Abiraterone Acetate 4 XRP6258 2 Standard of Care 2 talazoparib 1 sipuleucel-T 1 rucaparib 1 pembrolizumab 1 olaparib 1 gallium 68 PSMA-11 1 fludrocortisone acetate 1 darolutamide 1 apalutamide 1 Zuclomiphene 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisolone 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Midazolam 1 Lutetium-177 1 Lutetium 1 Lenograstim 1 LY3023414 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Carboplatin × Genitourinary × Clear all

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡